Arrhythmias & electrophysiology
Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization
Main finding · Incremental annualized cost per patientResult — go to the resultIncremental annualized increased cost 12,789 $ per patient (± $161,749)Authors' conclusion
Presence of device-recognized AF was associated with increased health care cost. Among those with AF, patients with PeAF had the highest health care costs.
Study context
- Population
- Cardiac implantable electronic device (CIED) patients transmitting data ≥6 months postimplantation, Optum Clinformatics US claims database linked with Medtronic CareLink, 2015–20207,798 (36.5%) with atrial fibrillation (AF)
- Participants
- 21,391 patients
- Exposure
- Device-recognized AF vs no AF
- AFn = 7,798
- Outcome
- Incremental annualized per-patient health care cost (2020 US dollars) of device-recognized AF vs no AF
Methodological detailsclaims database linked with device database, adjusted for region, insurance type, CHA2DS2-VASc score and implantation year
- Claims database linked with device database
- Adjusted for region, insurance type, CHA2DS2-VASc score and implantation year
Main finding
Incremental annualized cost per patient
Incremental annualized increased cost
12,789 $ per patient (± $161,749)
As reported in the abstract
Observational data: associations, not effects.
Further findings
Cost by AF type
- Among those with AF, persistent atrial fibrillation (PeAF) associated with the highest cost, driven by increased inpatient and outpatient hospitalization encounters, HF hospitalizations and AF-specific interventions
Original publication
Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization. JACC Clin Electrophysiol. Published 28 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →